Amerise Biosciences share news, announcements and annual reports
BSE: 531681Industrial ProductsSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.83.
30 Oct: open ₹0.83, high ₹0.84, low ₹0.79
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5.42 Cr5,065th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.03
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −1.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,19,779
Amerise Biosciences share news and announcements
387 announcements, routine notices left out, newest first. Page 5 of 8.
Oct 2020
2 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2020
19 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....19 Sep · Meeting
1 Sep · Intimation For Change In Address Of Registrar And Share Transfer Agent (RTA)
Aug 2020
26 Aug · Board meeting
Meeting on 1 Sep 2020: quarterly results24 Aug · Reg. 34 (1) Annual Report
24 Aug · Meeting
Jul 2020
18 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....6 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 06 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2020
22 Jun · Submission Of Half Yearly Disclosure On Related Party Transactions
20 Jun · Update Details On Corporate Information Of The Company.
5 Jun · Board meeting
Meeting on 18 Jun 2020: audited results3 Jun · Board meeting
Meeting on 9 Jun 2020: audited resultsNot held on this date
May 2020
21 May · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.
6 May · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 04 May · Compliance Certificate Pursuant To Reg 7(3) LODR For 31.03.2020
Apr 2020
10 Apr · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
Feb 2020
Jan 2020
20 Jan · Board meeting
Meeting on 3 Feb 2020: quarterly results16 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....1 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Oct 2019
16 Oct · Compliance Certificate Pursuant To Regulation 7(3) Of The Sebilisting Obligations And Disclosure Requirements) Regulations,2015 For The Period From April 1, 2019 To September 30, 2019.
16 Oct · Submission Of Certificate By PCS Under Regulation 40(9) Of The SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 .
15 Oct · Board meeting
Meeting on 24 Oct 2019: quarterly results9 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....2 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2019
21 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2019
22 Aug · Reg. 34 (1) Annual Report
22 Aug · Meeting
6 Aug · Announcement Under Regulation 30 (LODR) Updation Of Directors Of The Company.
6 Aug · Announcement Under Regulation 30 ( LODR ) Intimation For Change In Address & Contact Details Of Registrar And Share Transfer Agent (RTA)
Jul 2019
19 Jul · Board meeting
Meeting on 29 Jul 2019: quarterly results